CAR T-Cell Therapy: A Promising Modality for Autoimmune Diseases.

Thakral, Deepshi; Ramanan, Tejas; Bagri, Narendra Kumar

Thakral, Deepshi; Ramanan, Tejas; Bagri, Narendra Kumar.

Afiliação

Thakral D; Laboratory Oncology Unit, Dr BRAIRCH, All India Institute of Medical Sciences (AIIMS), New Delhi, India.
Ramanan T; Medical Student, University of Birmingham, Birmingham, United Kingdom.
Bagri NK; Division of Pediatric Rheumatology, Department of Pediatrics, All India Institute of Medical Sciences (AIIMS), New Delhi, India. Correspondence to: Dr Narendra Kumar Bagri, Additional Professor, Division of Pediatric Rheumatology, Department of Pediatrics, All India Institute of Medical Sciences (AIIMS), New Delhi- 110029. drnarendrabagri@yahoo.co.in.

Indian Pediatr ; 2024 08 26.

Article em En | MEDLINE | ID: mdl-39193924

ABSTRACT

ABSTRACT

Chimeric Antigen Receptor (CAR)-T cells have emerged as a promising immune effector cell-based therapy. With promising results and approval for the treatment of hematological malignancies, we discuss the scope of this novel therapeutic modality in systemic autoimmune diseases and immune-mediated inflammatory disorders refractory to conventional and biological disease-modifying agents.

Buscar no Google

Imprimir

XML

PubMed Links

Coleções: 01-internacional Temas: Geral Base de dados: MEDLINE Idioma: En Revista: Indian Pediatr Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Índia

Buscar no Google

Imprimir

XML

PubMed Links